These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 9605768

  • 1. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
    Sugiura Y, Shimada H, Seeger RC, Laug WE, DeClerck YA.
    Cancer Res; 1998 May 15; 58(10):2209-16. PubMed ID: 9605768
    [Abstract] [Full Text] [Related]

  • 2. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN.
    J Pathol; 2000 Jul 15; 191(3):245-56. PubMed ID: 10878545
    [Abstract] [Full Text] [Related]

  • 3. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y.
    Cancer Res; 1997 May 15; 57(10):2055-60. PubMed ID: 9158005
    [Abstract] [Full Text] [Related]

  • 4. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
    Jones JL, Glynn P, Walker RA.
    J Pathol; 1999 Oct 15; 189(2):161-8. PubMed ID: 10547569
    [Abstract] [Full Text] [Related]

  • 5. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct 15; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

  • 6. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M, Okada Y.
    Cancer Res; 1999 Jan 15; 59(2):467-73. PubMed ID: 9927064
    [Abstract] [Full Text] [Related]

  • 7. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
    Matsumoto F, Uzuki M, Kaneko C, Rikimaru A, Kokubun S, Sawai T.
    Ryumachi; 1997 Oct 15; 37(5):688-95. PubMed ID: 9396371
    [Abstract] [Full Text] [Related]

  • 8. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

  • 9. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
    Janowska-Wieczorek A, Marquez LA, Matsuzaki A, Hashmi HR, Larratt LM, Boshkov LM, Turner AR, Zhang MC, Edwards DR, Kossakowska AE.
    Br J Haematol; 1999 May 01; 105(2):402-11. PubMed ID: 10233411
    [Abstract] [Full Text] [Related]

  • 10. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T, Okada Y, Nakanuma Y.
    Hepatology; 1996 Jun 01; 23(6):1341-4. PubMed ID: 8675149
    [Abstract] [Full Text] [Related]

  • 11. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
    Fridman R, Toth M, Peña D, Mobashery S.
    Cancer Res; 1995 Jun 15; 55(12):2548-55. PubMed ID: 7780967
    [Abstract] [Full Text] [Related]

  • 12. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
    Hirata M, Sato T, Tsumagari M, Shimada A, Nakano H, Hashizume K, Ito A.
    Biol Reprod; 2003 Apr 15; 68(4):1276-81. PubMed ID: 12606436
    [Abstract] [Full Text] [Related]

  • 13. Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells.
    Taraboletti G, Sonzogni L, Vergani V, Hosseini G, Ceruti R, Ghilardi C, Bastone A, Toschi E, Borsotti P, Scanziani E, Giavazzi R, Pepper MS, Stetler-Stevenson WG, Bani MR.
    Exp Cell Res; 2000 Aug 01; 258(2):384-94. PubMed ID: 10896789
    [Abstract] [Full Text] [Related]

  • 14. Matrix metalloproteinases and their inhibitors.
    Kugler A.
    Anticancer Res; 1999 Aug 01; 19(2C):1589-92. PubMed ID: 10365151
    [Abstract] [Full Text] [Related]

  • 15. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S, Moore BA, Alexander-Lister LD, Hallit SL, Windsor LJ, Engler JA.
    Cancer Res; 2001 Aug 15; 61(16):6264-75. PubMed ID: 11507081
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C, Loher F, Zang C, Ismair MG, Petrides PE.
    Clin Cancer Res; 1999 May 15; 5(5):1115-24. PubMed ID: 10353746
    [Abstract] [Full Text] [Related]

  • 17. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
    Baumann P, Zigrino P, Mauch C, Breitkreutz D, Nischt R.
    Br J Cancer; 2000 Nov 15; 83(10):1387-93. PubMed ID: 11044366
    [Abstract] [Full Text] [Related]

  • 18. Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay.
    Tsunezuka Y, Kinoh H, Takino T, Watanabe Y, Okada Y, Shinagawa A, Sato H, Seiki M.
    Cancer Res; 1996 Dec 15; 56(24):5678-83. PubMed ID: 8971175
    [Abstract] [Full Text] [Related]

  • 19. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
    Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y.
    Am J Pathol; 1999 Feb 15; 154(2):417-28. PubMed ID: 10027400
    [Abstract] [Full Text] [Related]

  • 20. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
    Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR.
    Oncol Res; 1993 Feb 15; 5(1):19-28. PubMed ID: 8369572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.